PPT-Metastatic Breast Cancer (MBC) Challenge

Breast Cancer How important is it It is the most common cancer among women in lowerandmiddleincome in Asian countries Its cost to society in terms of use of healthcare resources . . Dr.Mina. . Tajvidi. Radiation . oncologist. . Fewer than 10 percent of women present with metastatic disease at the time of diagnosis. the majority of women who relapse after definitive therapy for early stage or locally advanced disease will do so with disseminated metastatic disease rather than an isolated local recurrence. Jennifer M. Matro, MD. Rena Rowan Breast Center. Abramson Cancer Center. University of Pennsylvania. Overview. What is metastatic breast . c. ancer (MBC)?. Who is at risk?. Subtypes of Breast Cancer. What’s Positive about Triple Negative Breast Cancer ? Julie R. Gralow, M.D. Jill Professor Endowed Professor of Breast Cancer Director, Breast Medical Oncology Seattle Cancer Care Alliance University of Washington School of Medicine Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings Christy A Russell, MD Keck School of Medicine University of Southern California Metastatic Breast Cancer An Interactive Oncology Grand Rounds Series. Joyce O’Shaughnessy, MD. Chair, Breast Cancer Research Program. Baylor Charles A Sammons Cancer Center. Celebrating Women Chair in Breast Cancer Research. Cike PengDr schummarkers of metastatic breast cancerFach/Einrichtung DKFZ Deutsches KrebsforschungszentrumDoktormutter Prof Barbara BurwinkelBreast cancer BC is the most common malignant disease in wo group. of diseases. . All forms of cancer cause cells in the body to change and grow out of control. . Most types of cancer cells form a lump or mass called a . tumor. . . The tumor can invade and destroy healthy tissue. Cells from the tumor can break away and travel to other parts of the body. There they can continue to grow. . L. MEYSKENS, D. (32, 33), and hormonal (42, 46, (60, 78). 57, 66, cancer in is less Klinefelter'n syndrome with male authors measured et al. the formation ofestrone results rerrmin in males been repo ENHERTUSignificantlyImproved Both ProgressionFree and Overall Survival in DESTINYBreast04 Trial in Patients with HER2 Low Metastatic Breast Cancer FirstHER2 low metastatic breast cancer ENHERTU of Genetics of ovarian cancer. 49F. Underwent risk-reduction surgery. Total hysterectomy and bilateral . salpingo. -oophorectomy. Significant family history . Sister passed away in her 40s due to breast cancer. m. CSPC). 1. Neal Shore, MD, FACS. Carolina Urologic Research Center. Myrtle Beach, SC. Alicia Morgans, MD, MPH. Northwestern University. Chicago, IL. PROSTATE CANCER IS HORMONE DEPENDENT. 2. Huggins CB. Nobel lecture. Available from . Background of lower back pain for 3/12 . No past medical Hx.. Social Hx: . Married 2 small children, works in hospital admin. Regular Menstrual periods. Family Hx: . Aunt: Breast Ca 55. Aims. O/E:. Palpable LN under the right axilla. Key recommendations. 1. National and local workforce planning is essential. Health Education England and all Cancer Alliances should urgently ensure there are enough healthcare professionals to deliver high-quality and timely diagnosis, treatment and care to local women.. Jo Anne Zujewski, M.D.. June 2019. Thimphu. , Bhutan. Define the breast cancer. Is the cancer operable?. Stage 1: systemic therapy after surgery (and radiation if breast conservation). Stage 2: systemic therapy before or after therapy.